Clinical Trials Browser

OTHER × Neuroendocrine Tumors × Leflunomide × Clear all

NCT06540937 2024-08-07

Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor

Phase 2 Recruiting

Multiple Endocrine Neoplasia, Neuroendocrine Tumors